1. Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study. (July 2021) Authors: Vitkon, Roy; Netanely, Dan; Levi, Shai; Ziv-Baran, Tomer; Ben-Yzak, Ronit; Katz, Ben-Zion; Benyamini, Noam; Trestman, Svetlana; Mittelman, Moshe; Cohen, Yael; Avivi, Irit Journal: Therapeutic advances in hematology Issue: Volume 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗